Progesterone receptor profile in the decidua and fetal membrane

Frontiers in Bioscience

Volumn 12, Issue 2, 2007, Pages 634-648

  Goldman, Shlomit ^a   Shalev, Eliezer ^a,b  

^a HAEMEK MEDICAL CENTER   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Calcium influx; Decidua; Fetal membrane; Inflammatory mediators; Matrix metalloproteinases; Progesterone receptor; Prostaglandins; Review

Indexed keywords

MAMMALIA; PRIMATES;

EID: 34249800369     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/2088     Document Type: Article

References (125)

1. Challis JRG, S.G. Matthews, W. Gibb and S.J. Lye: Endocrine and Paracrine Regulation of Birth at Term and Preterm. Endocrine Reviews 21, 514-550 (2002).
2. Siiteri PK and M. Seron-Ferre: Some new thoughts on the feto-placental unit and parturition in primates. In: Novy MJ, Resko JA, eds: Fetal endocrinology. New York: Academic Press pp. 1-34 (1981)
3. Garfield RE, D. Merrett and A.K Grover: Gap junction formation and regulation in myometrium. Am J Physiol 239, C217-28(1980)
4. Shi L, S.Q. Shi, R.L. Given, H. von Hertzen and R.E. Garfield: Synergistic effects of antiprogestins and iNOS or aromatase inhibitors on establishment and maintenance of pregnancy. Steroids 68, 1077-1084 (2003)
5. Astle S, D.M Slater and S. Thomton: The involvement of progesterone in the onset of human labour. Eur J Obstet Gynecol Reprod Biol 108, 177-81 (2003)
6. Meis P.J, M. Klebanoff, E. Thorn, M.P. Dombrowski, B. Sibai, A.H. Moawad, C.Y. Spong, J.C Hauth, M.,Miodovnik and MW Varner: Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate N Engl J Med 348, 2379-2385 (2003)
7. Smith R, S. Mesiano, and S. McGrath: Hormone trajectories leading to human birth. Regul Pept 108, 159-164 (2002).
8. Allport VC, D. Pieber, D.M. Slater, R. Newton, J.O. White, P.R. and Bennett: Human labour is associated with nuclear factor-kappaB activity which mediates cyclooxygenase-2 expression and is involved with the 'functional progesterone withdrawal'. Mol Hum Reprod 7, 581-586 (2001).
9. Rezapour M, T. Backstrom, B. Lindblom and U. Ulmsten: Sex steroid receptors and human parturition. Obstet Gynecol 89, 918-924 (1997).
10. Karalis K, G. Goodwin and J.A Majzoub: Cortisol blockade of progesterone: a possible molecular mechanism involved in the initiation of human labour. Nat Med 2, 556-560 (1996).
11. Shynlova O, J.A. Mitchell, A. Tsampalieros, B.L Langille and S.J. Lye: Progesterone and Gravidity Differentially Regulate Expression of Extracellular Matrix Components in the Pregnant Rat Myometrium. Biol Reprod 70, 986-92 (2004)
12. Roh CR, W.J. Oh, B.K Yoon and J.H Lee: Upregulation of matrix metalloproteinase-9 in human myometrium during labour: a cytokine-mediated process in uterine smooth muscle cells. Mol Hum Reprod 6, 96-102 (2000).
13. Goldman S, A. Weiss, I. Almalah and E. Shalev: Progesterone receptor expression in human decidua and fetal membranes before and after contractions: possible mechanism for functional progesterone withdrawal. Mol Hum Reprod 11, 269-77 (2005)
14. Graham J.D. and C.L. Clarke: Expression and transcriptional activity of progesterone receptor A and progesterone receptor B in mammalian cells. Breast Cancer Res 4, 187-90 (2002)
15. Kastner P, A. Krust, B. Turcotte, U. Stropp, L Tora, H. Gronemeyer, and P. Chambon: Two distinct estrogenregulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B. EMBO .J 9, 1603-1614 (1990).
16. Vegeto E, M.M Shabaz, D.X Wen, M.E Goldman, B.W O'Malley and D.P McDonnell: Human progesterone receptor A form is a cell- and promoter-specific represser of human progesterone receptor B function. Mol Endocrinol 7, 1244-1255 (1993)
17. Peluso J.J, G. Fernandez, A. Pappalardo and B.A White: Characterization of a putative membrane receptor for progesterone in rat granulosa cells. Biol Reprod 65, 94-101 (2001)
18. Peluso J.J, G. Fernandez, A. Pappalardo and B.A White: Membrane-initiated events account for progesterone's ability to regulate intracellular free calcium levels and inhibit rat granulosa cell mitosis. Biol Reprod 67, 379-85 (2002)
19. Luconi M, L. Bonaccorsi, M. Maggi, P. Pecchioli, C. Krausz, G. Forti and E. Baldi: Identification and characterization of functional nongenomic progesterone receptors on human sperm membrane. J Clin Endocrinol Metab 83, 877-85(1998)
20. Sartorius C.A, M.Y Melville, A.R Hovland, L. Tung, G.S Takimoto and K.B. Horwitz: A third transactivation function (AF3) of human progesterone receptors located in the unique N-terminal segment of the B isoform. Mol Endocrinol 8, 1347-1360 (1994)
21. Richer J.K, B.M Jacobsen, N.G Manning, M.G Abel, D.M Wolf and K.B Horwitz: Differential gene regulation by the two progesterone receptor isoforms in human breast cancer cells. J Biol Chem 277, 5209-5218 (2002)
22. Mote P.A, R.L Balleine, E.M McGowan and C.L Clarke: Heterogeneity of progesterone receptors A and B expression in human endometrial glands and stroma. Hum Reprod 15, 48-56(2000)
23. Mote P.A, S. Bartow, N. Tran and C.L Clarke: Loss of co-ordinate expression of progesterone receptors A and B is an early event in breast carcinogenesis. Breast Cancer Res Treat 72, 163-172(2002)
24. Biserka Mulac-Jericevic and Orla M Conneely: Reproductive tissue selective actions of progesterone receptors Reproduction 128, 139-146 (2004)
25. Giangrande P.H, E.A Kimbrel, D.P Edwards and D.P McDonnell: The opposing transcriptional activities of the two isoforms of the human progesterone receptor are due to differential cofactor binding. Mol Cell Biol 20, 3102-15 (2000)
26. Pieber D, V.C Allport and P.R Bennett: Progesterone receptor isoform A inhibits isoform B-mediated transactivation in human amnion. Eur J Pharmacol 427, 7-11 (2001)
27. Brenner R. M and O.D Slayden: Steroid receptors in blood vessels of the rhesus macaque endometrium: a review. Arch Histol Cytol 67, 411-6 (2004)
28. Mulac-Jericevic B and O.M Conneely: Reproductive tissue selective actions of progesterone receptors. Reproduction 128, 139-46 (2004)
29. Wei L.L, C. Gonzalez-Aller, W.M Wood, L.A Miller, K.B Horwitz: 5'-Heterogeneity in human progesterone receptor transcripts predicts a new amino-terminal truncated "C"-receptor and unique A-receptor messages. Mol Endocrinol 4,1833-40 (1990)
30. Wei L.L, P. Hawkins, C. Baker, B. Norris, P.L Sheridan and P.G Quinn: An amino-terminal truncated progesterone receptor isoform, PRc, enhances progestininduced transcriptional activity. Mol Endocrinol 10, 1379-87(1996)
31. Wen D.X, Y.F Xu, D.E Mais, M.E Goldman and D.P McDonnell: The A and B isoforms of the human progesterone receptor operate through distinct signaling pathways within target cells. Mol Cell Biol 14, 8356-8364 (1994)
32. Vegeto E, M.M Shahbaz, D.X Wen, M.E Goldman, B.W O'Malley and D.P McDonnell: Human progesterone receptor A form is a cell- and promoter-specific represser of human progesterone receptor B function. Mol Endocrinol 7, 1244-1255 (1993)
33. Sartorius C.A, M.Y Melville, A.R Hovland, L. Tung, G.S Takimoto and K.B Horwitz: A third transactivation function (AF3) of human Progesterone receptors located in the unique N-terminal segment of the 62 B-isoform. Mol endocrinol 8, 1347-1360 (1994)
34. Kastner P, A. Krust, B. Turcotte, Stropp, U. L. Tora and H Gronemeyer: Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B.EMBO J 9, 1603-1614 (1990)
35. Kastner P, A. Krust, B. Turcotte, U. Strupp, L. Tora, H. Gronemeyer and P. Chambon: Two distinct estrogenregulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B. The EMBO Journal 9, 1603-1614 (1990)
36. Conneely O.M, D.M Kettelberger, MJ Tsai, W.T Schrader and B.W O'Malley: The chicken progesterone receptor A and B isoforms are products of an alternate translation initiation event. J. Biol. Chem 264, 14062-14064 (1989)
37. Lessey B.A, P.S Alexander and K.B Horwitz: The subunit structure of human breast cancer progesterone receptors: characterization by chromatography and photoaffinity labeling. Endocrinology 112, 1267-1274 (1983)
38. Xiaotao Li and Bert W. O'Malley: Unfolding the Action of Progesterone Receptors J. Biol. Chem 278, 39261-39264 (2003)
39. Chauchereau A, J.F Savouret and E. Milgrom: Control of biosynthesis and post-transcriptional modification of the progesterone receptor. Biol Reprod. 46, 174-7 (1992)
40. Carolyn L. Smith and Bert W. O'Malley: Coregulator Function: A Key to Understanding Tissue Specificity of Selective Receptor Modulators Endocrine Reviews 25, 45-71 (2004)
41. Giangrande PH and D.P McDonnell: The A and B isoforms of the human progesterone receptor: two functionally different transcription factors encoded by a single gene. Recent Progress in Hormone Research 54, 291-313 (1999)
42. Raman V, Tamori A, Vali M, Zeller K, Korz D, Sukumar S. HOXA5 regulates expression of the progesterone receptor. J. Biol Chem. 2000 Aug 25;275:26551-5.
43. Attardi BJ, J. Burgenson, S.A Hild, J.R Reel and R.P Blye: CDB-4124 and its putative monodemethylated metabolite, CDB-53, are potent antiprogestins with reduced antiglucocorticoid activity: in vitro comparison to mifepristone and CDB-2914. Mol Cell Endocrinol 25, 111-23. (2002)
44. Ni X, Y. Hou, R. Yang, X. Tang, R. Smith and R.C Nicholson: Progesterone receptors A and B differentially modulate corticotropin-releasing hormone gene expression through a cAMP regulatory element. Cell Mol Life Sci 61, 1114-22(2004)
45. Miyamoto T, J. Watanabe, H. Hata, T. Jobo, M. Kawaguchi, M. Hattori, M. Saito and H..Kuramoto: Significance of progesterone receptor-A and -B expressions in endometrial adenocarcinoma. J Steroid Biochem Mol Biol 92, 111-8 (2004)
46. Ann B.S., J.H Choi, K.C Choi and P.C.Leung: Differential role of progesterone receptor isoforms in the transcriptional regulation of human gonadotropin-releasing hormone I (GnRH I) receptor, GnRH I, and GnRH II. J Clin Endocrinol Metab 90, 1106-13 (2005)
47. Tora L., H. Gronemeyer, B. Turcotte, M.P Gaub and P. Chambon: The N-terminal region of the chicken progesterone receptor specifies target gene activation. Nature 333, 185-188(1988)
48. Meyer M.E, C. Quirin-Stricker, T. Lerouge, M.T Bocquel and H. Gronemeyer: A limiting factor mediates the differential activation of promoters by the human progesterone receptor isoforms. J. Biol. Chem 267, 10882-10887(1992)
49. Hewetson A and B.S An Chilton: Spl-NF-Y/progesterone receptor DNA binding-dependent mechanism regulates progesterone-induced transcriptional activation of the rabbit RUSH/SMARCA3 gene. J. Biol Chem 278, 40177-85 (2003)
50. Lange C.A.: Making Sense of Cross-Talk between Steroid Hormone Receptors and Intracellular Signaling Pathways: Who Will Have the Last Word? Mol. Endocrinol 18, 269-278(2004)
51. Xiaotao L. and W.B. O'Malley: Unfolding the Action of Progesterone Receptors J. Biol. Chem 278, 39261-39264 (2003)
52. Bramley T.A: Non-genomic progesterone receptors in the mammalian ovary: some unresolved issues. Reproduction 125, 3-15 (2003)
53. Rae M.T., G.S Menzies and T.A Bramley: Bovine ovarian non-genomic progesterone binding sites: presence in follicular and luteal cell membranes. J Endocrinol 159, 413-427 (1998)
54. Mani S: Signalling mechanisms in progesterone-neurotransmitter interactions. J. Mol. Endocrinol 30, 127-37 (2003)
55. Krusekopf S, A. Chauchereau, E. Milgrom, D. Henderson and A.C Cato: Co-operation of progestational steroids with epidermal growth factor in activation of gene expression in mammary tumor cells. J. Steroid Biochem. Mol. Biol 40, 239-245 (1991)
56. Groshong S.D, G.I Owen, B. Grimison, I.E Schauer, M.C. Todd, T.A. Langan, R.A Sclafani, C.A Lange and K.B Horwitz: Biphasic regulation of breast cancer cell growth by progesterone: role of the cyclin-dependent kinase inhibitors, p21 and p27(Kipl). Mol Endocrinol 11, 1593-1607 (1997)
57. Owen GI, J.K Richer, L. Tung, G. Takimoto and K.B Horwitz: Progesterone regulates transcription of the p21 (WAF1) cyclin-dependent kinase inhibitor gene through Spl and CBP/p300. J. Biol. Chem 273, 10696-10701 (1999)
58. Henderson D and T. Wilson: Reduced binding of progesterone receptor to its nuclear response element after human labour onset. Am. J. Obstet Gynecol 185, 579-585 (2001)
59. Padayachi T, R.J. Pegoraro, L. Rom and S.M Joubert: Enzyme immunoassay of oestrogen and progesterone receptors in uterine and intrauterine tissue during human pregnancy and labour. J Steroid Biochem Mol Biol 37, 509-11 (1990)
60. Henderson D and T. Wilson: Reduced binding of progesterone receptor to its nuclear response element after human labour onset. Am. J. Obstet Gynecol 185, 579-585 (2001)
61. Condon J.C, P. Jeyasuria, J.M. Faust, J.W. Wilson, C.R. Mendelson: A decline in the levels of progesterone receptor coactivators in the pregnant uterus at term may antagonize progesterone receptor function and contribute to the initiation of parturition. Proc Natl Acad Sci USA 100, 9518-23 (2003)
62. Chwalisz K, M. Benson, P. Scholz, J Daum, H.M Beier, and C. Hegele-Hartung: Cervical ripening with the cytokines interleukin-8, interleukin-lb and tumour necrosis factor a in guinea-pigs Human. Reproduction 9, 2173-2181 (1994)
63. Madsen G, T. Zakar, C.Y. Ku, B.M. Sanborn, R. Smith and S. Mesiano: Prostaglandins differentially modulate progesterone receptor-A and B expression in human myometrial cells: evidence for prostaglandininduced functional progesterone withdrawal. J Clin Endocrinol Metab 89, 1010-1013 (2004)
64. Duffy D.M, T.A Molskness and R.L Stouffer: Progesterone receptor messenger ribonucleic acid and protein in luteinized granulosa cells of rhesus monkeys are regulated in vitro by gonadotropins and steroids. Biol Reprod 54, 888-895 (1996)
65. El-Hefnawy T, P.R. Manna, M. Luconi, E. Baldi, IP. Slotte and I. Huhtaniemi: Progesterone action in a murine Ley dig rumor cell line (mLTC-1), possibly through a nonclassical receptor type. Endocrinology 141, 247-255 (2000)
66. Sanborn B.M and K. Anwer: Hormonal regulation of myometrial intracellular calcium. In: Garfield RE (ed) Uterine Contractility. Serono Symposia USA, Norwell, M A, pp 69-82 (1990)
67. Spencer G.G, I. Khan and A.K. Graver: Ca21 regulation in smooth muscle. In: Garfield RE (ed) Uterine Contractility. Serono Symposia USA, Norwell, MA, pp 53-68 (1990)
68. Hirst J.J, F.J Teixeira, T. Zakar and D.M. Olson: Prostaglandin endoperoxide-H synthase-1 and -2 35 messenger ribonucleic acid levels in human amnion with spontaneous labour onset. J Clin Endocrinol Metab 80, 517-523 (1995)
69. Mitchell M.D and M.S. Trautman: Molecular mechanisms regulating prostaglandin action. Mol Cell Endocrinol 93, C7-C10 (1993)
70. van Meir C.A, S.G. Matthews, M.J.N.C Keirse, M.M Ramirez, A.D Bocking and J.R.G Challis: 15Hydroxyprostaglandin dehydrogenase (PGDH): implications in preterm labor with and without ascending infection. J Clin Endocrinol Metab 82, 969-976 (1997)
71. Chwalisz K, M. Benson, P. Scholz, J. Daum, H.M. Beier, and C. Hegele-Hartung: Cervical ripening with the cytokines interleukin-8, interleukin-lb and tumour necrosis factor a in guinea-pigs. Hum. Reprod 9, 2173-2181 (1994)
72. Barclay C.G, J.E Brennand, R.W Kelly and A.A. Calder: Interleukin-8 production by the human cervix Am. Am. J. Obstet Gynecol 169, 625-632 (1993)
73. Myers D.A and Nathanielsz P.W: Biologic basis of term and preterm labor.Clin Perinatol 20, 9-28 (1993)
74. Cook J.L, D.B Zaragoza, D.H. Sung and D.M. Olson: Expression of myometrial activation and stimulation genes in a mouse model of preterm labor: myometrial activation, stimulation, and preterm labor. Endocrinology 141, 1718-28 (2000)
75. Charles. J.R and D.M. oison: Parturition. In: Knobil E, Neill J, eds: The Physiology of Reproduction. New York: Raven Press, (1988)
76. Senior J, K. Marshall, R. Sangha, G.S. Baxter and J.K. Clayton: In vitro characterization of prostanoid EPreceptors in the non-pregnant human myometrium.Br J Pharmacol 102, 747-53 (1991)
77. Senior J, K. Marshall, R. Sangha and J.K. Clayton: In vitro characterization of prostanoid receptors on human myometrium at term pregnancy. Br J Pharmacol 108, 501-6 (1993)
78. Parkington H.C, M.A. Tonta, N.K. Davies, S.P. Brennecke and H.A. Coleman: Hyperpolarization and slowing of the rate of contraction in human uterus in pregnancy by prostaglandins E2 and f2alpha: involvement of the Na+ pump. J Physio 514, 229-43 (1999)
79. Hirst J.J, J.E Mijovic, T. Zakar and D.M Olson: Prostaglandin endoperoxide H synthase-1 and -2 mRNA levels and enzyme activity in human decidua at term labor. J Soc Gynecol Investig 5, 13-20 (1998)
80. Hirst J.J, F.J Teixeira, T. Zakar and D.M Olson: Prostaglandin endoperoxide-H synthase-1 and -2 messenger ribonucleic acid levels in human amnion with spontaneous labor onset. J Clin Endocrinol Metab 80, 517-23 (1995)
81. Hirst J.J, F.J Teixeira, T. Zakar and D.M Olson: Prostaglandin H synthase-2 expression increases in human gestational tissues with spontaneous labour onset. Reprod Fertil Dev 1, 633-7 (1995)
82. Challis J.R, D.M. Sloboda, N. Alfaidy, S.J Lye, W. Gibb, F.A Patel, W.L Whittle and J.P Newnham: Prostaglandins and mechanisms of preterm birth. Reproduction 124, 1-17 (2002)
83. Loudon J.A, C.L Elliott, F. Hills and P.R Bennett: Progesterone represses interleukin-8 and cyclo-oxygenase-2 in human lower segment fibroblast cells and amnion epithelial cells. Biol Reprod 69, 331-7 (2003)
84. Sooranna S.R, Y. Lee, L.U Kim, A.R Mohan, P.R Bennett and M. R Johnson: Mechanical stretch activates type 2 cyclooxygenase via activator protein-1 transcription factor in human myometrial cells. Mol Hum Reprod 10, 109-13 (2004)
85. Dong Y.L and C. Yallampalli: Pregnancy and exogenous steroid treatments modulate the expression of relaxant EP (2) and contractile FP receptors in the rat uterus. Biol Reprod 62, 533-9 (2000)
86. Ulug U, S. Goldman, I. Ben-Shlomo and E Shalev: Matrix metalloproteinase (MMP)-2 and MMP-9 and their inhibitor, TIMP-1, in human term decidua and fetal membranes: the effect of prostaglandin F (2alpha) and indomethacin. Mol Hum Reprod 7, 1187-93 (2001)
87. Maymon E, Romero R, Pacora P, Gomez R, Mazor M, Edwin S, Chaiworapongsa T, Kim JC, Yoon BH, Menon R, Fortunate S, Berry SM. A role for the 72 kDa gelatinase (MMP-2) and its inhibitor (TIMP-2) in human parturition, premature rupture of membranes and intraamniotic infection. J Perinat Med 29, 308-16 (2001).
88. Fortunate S.J and R. Menon: Distinct molecular events suggest different pathways for preterm labor and premature rupture of membranes. Am J Obstet Gynecol 184, 1399-405(2001)
89. Vadillo-Ortega F and G. Estrada-Gutierrez: Role of matrix metalloproteinases in preterm labour. BJOG 112, Suppl 1, 19-22(2005)
90. Goldman S, A. Weiss, V. Eyali and E. Shalev: Differential activity of the gelatinases (matrix metalloproteinases 2 and 9) in the fetal membranes and decidua, associated with labour. Mol Hum Reprod 9, 367-73 (2003)
91. Fortunate S.J, B. LaFleur and R. Menon: Collagenase-3 (MMP-13) in fetal membranes and amniotic fluid during pregnancy. Am J Reprod Immunol 49, 120-5 (2003)
92. Basu A and B. G Rowan: Genes related to estrogen action in reproduction and breast cancer. Front Biosci 10, 2346-72 (2005)
93. Laudanski P, S. Redzko, J. Przepiesc, M. Koda, S. Wolczynski, S. Sulkowskt and J. Urban: Expression of estrogen receptors alpha and beta in term human myometrium. Reprod Biol 4, 305-11 (2004)
94. Minorics R, E. Ducza, A. Marki, E. Paldy and G. Falkay: Investigation of estrogen receptor alpha and beta mRNA expression in the pregnant rat uterus. Mol Reprod Dev 68, 463-8 (2004)
95. Murata T, K. Narita, K. Honda, S. Matsukawa, T. Higuchi: Differential regulation of estrogen receptor alpha and beta mRNAs in the rat uterus during pregnancy and labor: possible involvement of estrogen receptors in oxytocin receptor regulation. Endocr J 50, 579-87 (2003)
96. Mesiano S: Myometrial progesterone responsiveness and the control of human parturition. J Soc Gynecol Investig 11, 193-202 (2004)
97. Winkler M, B. Kemp, I. Classen-Linke, D.C. Fischer, S. Zlatinsi, J. Neulen, H.M Beier and W. Rath Estrogen receptor alpha and progesterone receptorA and B concentration and localization in the lower uterine segment in term parturition. J Soc Gynecol Investig 9, 226-232 (2002)
98. Wu W.X, J. Owiny, Q. Zhang, X.H. Ma and P.W Nathanielsz: Regulation of the estrogen receptor and its messenger ribonucleic acid in the ovariectomized sheep myometrium and endometrium: the role of estradiol and progesterone. Biol Reprod 55, 762-8 (1996)
99. Haluska G.J, N.B. West, M.J. Novy and R.M Brenner: Uterine estrogen receptors are increased by RU486 in late pregnant rhesus macaques but not after spontaneous labor. J Clin Endochnol Metab 70, 181-6 ( 1990)
100. Asboth G, S. Phaneuf, G.N Europe-Finner, M. Toth and A.L Bernai: Prostaglandin E2 activates phospholipase C and elevates intracellular calcium in cultured myometrial cells: involvement of EP1 and EP3 receptor subtypes. Endocrinology 137, 2572-9 (1996)
101. Wills F.L, W.D McCubbin and C.M Kay: Smooth muscle calponin-caltropin interaction: effect on biological activity and stability of calponin. Biochemistry 10, 5562-9 (1994)
102. Beyer E.C, J. Kistler, D.L Paul and D.A Goodenough: Antisera directed against connexin-43 peptides react with a 43 kD protein localized to gap junctions in myocardium and other tissues. J Cell Biol 108, 595-605(1989)
103. Hartshorne D.J, M. Ito and F. Erdodi: Myosin light chain phosphatase: subunit composition, interactions and regulation. J Muscle Res Cell Motil 19, 325-341 (1998)
104. Sanborn B.M and K. Anwer: Hormonal regulation of myometrial intracellular calcium. In: Garfield RE (ed) Uterine Contractility.Serono Symposia USA, Norwell, MA, pp 69-82 (1990)
105. Spencer G.G, I. Khan and A.K Graver: Ca21 regulation in smooth muscle. In: Garfield RE (ed) Uterine Contractility. Serono Symposia USA, Norwell, MA, pp 53-68 (1990)
106. Toro L, Stefani E, Erulkar S Hormonal regulation of potassium currents in single myometrial cells. Proc NatI AcadSciUSA 87, 2892-2895 (1990)
107. Lu F.X, K. Abel, Z. Ma, T. Rourke, D. Lu, J. Torten, M. McChesney and C.J. Miller: The strength of B cell immunity in female rhesus macaques is controlled by CD8+ T cells under the influence of ovarian steroid hormones. Clin Exp Immunol 128, 10-20 (2002)
108. Harper C.V and S. J Publicover: Reassessing the role of progesterone in fertilization-compartmentalized calcium signalling in human spermatozoa? Hum Reprod 20, 2675-80 (2005)
109. Kohan S.A and C.B Gundersen: Protein synthesis is required for the transition to Ca(2+)-dependent regulated secretion in progesterone-matured Xenopus oocytes. J Exp Zoolog A Camp Exp Biol 300, 113-25 (2003)
110. Bagowski C.P, J.W Myers and J. E Ferrell Jr: The classical progesterone receptor associates with p42 MAPK and is involved in phosphatidylinositol 3-kinase signaling in Xenopus oocytes. J. Biol. Chem 276, 37708-14 (2001)
111. Goldman S and E Shalev: The role of the matrix metalloproteinases in human endometrial and ovarian cycles. Ear J Obstet Gynecol Reprod Biol 111, 109-21 (2003)
112. Lovering F, Y. Zhang. Therapeutic potential of TACE inhibitors in stroke. Curr Drug Targets CNS Neural Disord 4, 161-8 (2005)
113. Tsafriri A: Ovulation as a tissue remodelling process: Proteolysis and cumulus expansion. Adv Exp Med Biol 377, 121-40 (1995)
114. Biggio J.R Jr, P.S. Ramsey, S.P Cliver, M.D. Lyon, R. L Goldenberg and K.D. Wenstrom: Midtrimester amniotic fluid matrix metalloproteinase-8 (MMP-8) levels above the 90th percentile are a marker for subsequent preterm premature rupture of membranes. Am. J Obstet Gynecol 192, 109-13 (2005)
115. Fortunate S.J, R. Menon, N.U. Ahmed, M. Bourgeois and G.A Dildy: Amniotic fluid concentrations of collagenase-1 and collagenase-3 are increased in polyhydramnios. J Perinat Med 32, 122-5 (2004)
116. Park K.H, T. Chaiworapongsa, Y.M. Kim, J. Espinoza, J. Yoshimatsu, S. Edwin, R. Gomez, B.H Yoon and R Romero: Matrix metalloproteinase 3 in parturition, premature rupture of the membranes, and microbial invasion of the amniotic cavity. J Perinat Med 31, 12-22 (2003)
117. Le Bouar G, L. Lassei and P. Poulain: Markers of infection and inflammation in the amniotic fluid: therapeutic contribution of amniocentesis J Gynecol Obstet Biol Reprod (Paris) 31(7 Suppl), 5S52-6 (2002)
118. Moon J.B, J.C. Kim, B.H. Yoon, R. Romero, G. Kim, S.Y. Oh, M. Kim and S.S. Shim: Amniotic fluid matrix metalloproteinase-8 and the development of cerebral palsy. J Perinat Med 30, 301-6 (2002)
119. Weiss A, S. Goldman, I. Ben Shlomo, V. Eyali, S. Leibovitz and E. Shalev: Mechanisms of matrix metalloproteinase-9 and matrix metalloproteinase-2 inhibition by N-acetylcysteine in the human term decidua and fetal membranes. Am. J Obstet Gynecol 189, 1758-63 (2003)
120. Osteen K.G, K.L Bruner-Tran and E. Eisenberg: Reduced progesterone action during endometrial maturation: a potential risk factor for the development of endometriosis. Fertil Steril 83, 529-37 (2005)
121. Osteen K.G, T.M Igarashi and K.L.Bruner-Tran: Progesterone action in the human endometrium: induction of a unique tissue environment which limits matrix metalloproteinase (MMP) expression Front Biosci 8, 78-86 (2003)
122. Kelly R.W: Inflammatory mediators and parturition. Rev Reprod 1, 89-96 (1996)
123. Moolwaney A.S and O.J. Igwe: Regulation of the cyclooxygenase-2 system by interleukin-lbeta through mitogen-activated protein kinase signaling pathways: A comparative study of human neuroglioma and neuroblastoma cells. Brain Res Mol Brain ResJun 137, 202-12 (2005)
124. Carp H: Cytokines in recurrent miscarriage. Lupus 13, 630-4 (2004)
125. Ragusa A, C.de Carolis, A. dal Lago, D. Miriello, G. Ruggiero, A. Brucato, M.P. Pisoni, M. Muscara, R. Merati, L. Maccario and M. Nobili.: Progesterone supplement in pregnancy: an immunologie therapy? Lupus 13, 639-42 (2004)